Shoulder Innovations reported second quarter 2026 net revenue of $17.2 million, a 56% increase from the prior year period, driven by a 50% rise in implant system sales to 2,238 units and higher average selling prices. The company raised its full-year 2026 net revenue guidance to $67–$69 million, reflecting approximately 42–46% growth over 2025. Additionally, Shoulder Innovations closed two new credit facilities totaling up to $50 million with Stifel Venture Banking to refinance existing debt and secure working capital capacity. The company operates in the medical technology industry, specializing in implant systems for shoulder arthroplasty.
